SwedenBIO - branschorganisationen för life science

Karessa Pharma Holding AB

Karessa’s business concept is to develop and commercialise innovative products with clear competitive advantages in the therapeutic area of erectile dysfunction. 

By combining the Company’s patented drug delivery platform with clinically tested and proven substances (such as Sildenafil and Tadalafil) the foundation is laid for a unique concept with great competitive advantages. From the patient perspective, a medicinal product with significantly faster effect is enabled – and thus reduces the need for planning. From the owner and investor perspectives, the concept entails a lower risk and shorter time to market, as compared with what is usual for drug development.

Kategorier: Pharma

Gå till Karessa Pharma Holding ABs hemsida